Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of HER-2 dependent cancer using an agent that modulates the activity of a miRNA

Treatment of HER-2 dependent cancer using an agent that modulates the activity of a miRNA

US Patent 11352627 · Granted Jun 7, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a2023
Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a2023
Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a2023
Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibi2020
Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibi2020
CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endoth2018
Polypeptides and nucleic acids for treating ErbB2-dependent cancers2015